PD-L1NEUT, Foxp3Treg, and NLR as New Prognostic Marker with Low Survival Benefits Value in Hepatocellular Carcinoma

by Lin Zhou PhD, Jing Wang MD, Shao-cheng Lyu PhD, Li-chao Pan PhD, Xian-jie Shi PhD, Guo-sheng Du PhD, Qiang He PhD
Published 2021-09-01